SARS-CoV-2 variants from mink evade inhibition by antibodies
Por um escritor misterioso
Descrição
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans with SARS-CoV-2 variants with altered biological properties. Researchers at the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, Germany, have now shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks. In addition, the mutation reduced the inhibition of the virus by antibodies produced in SARS-CoV-2 infected humans. These results show that SARS-CoV-2 can acquire mutations in minks that may reduce control of the virus by the human immune system. The study and findings have been published in Cell Reports.
White-tailed deer (Odocoileus virginianus) may serve as a wildlife reservoir for nearly extinct SARS-CoV-2 variants of concern
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS -CoV-2
Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine
New study traces back the progenitor genomes causing COVID-19 and geospatial spread
Spike protein mutations in novel SARS-CoV-2 'variants of concern' commonly occur in or near indels - Virological
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
Roles of host proteases in the entry of SARS-CoV-2, Animal Diseases
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma
Neutralizing Antibodies to SARS‐CoV‐2 Selected from a Human Antibody Library Constructed Decades Ago - Qiang - 2022 - Advanced Science - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
